胰島素樣生長因子結合蛋白2(IGFBP2)重組蛋白
Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
IBP2; IGF-BP53
- 編號RPA053Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量33.3kDa
- 實際分子量34kDa(差異分析請參閱說明書)
- 片段與標簽Ala34~Gln305 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點7.3
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1068 ¥ 2670 ¥ 5340 ¥ 16020 ¥ 40050
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| APA053Mu61 | 胰島素樣生長因子結合蛋白2(IGFBP2)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA053Mu01 | 胰島素樣生長因子結合蛋白2(IGFBP2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA053Mu01 | 胰島素樣生長因子結合蛋白2(IGFBP2)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA053Mu61 | 胰島素樣生長因子結合蛋白2(IGFBP2)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA053Mu05 | 胰島素樣生長因子結合蛋白2(IGFBP2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA053Mu02 | 胰島素樣生長因子結合蛋白2(IGFBP2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA053Mu03 | 胰島素樣生長因子結合蛋白2(IGFBP2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA053Mu04 | 胰島素樣生長因子結合蛋白2(IGFBP2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA053Mu01 | 胰島素樣生長因子結合蛋白2(IGFBP2)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA053Mu06 | 胰島素樣生長因子結合蛋白2(IGFBP2)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA053Mu71 | 胰島素樣生長因子結合蛋白2(IGFBP2)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEA053Mu | 胰島素樣生長因子結合蛋白2(IGFBP2)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA053Mu | 胰島素樣生長因子結合蛋白2(IGFBP2)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| British journal of cancer | A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. [pubmed:28664912] |
| Experimental and Therapeutic Medicine | Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D?LC?MS/MS [Doi: 10.3892/etm.2018.6818] |
| Nutrition and Cancer | Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer [Pubmed: 32286106] |
留言咨詢
